114 related articles for article (PubMed ID: 32664065)
1. Effect of myrtol on chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Liu L; Li S; Wu Y; Wang X; Huang D; Pei C; Wang F; Wang Z
Medicine (Baltimore); 2020 Jul; 99(28):e20692. PubMed ID: 32664065
[TBL] [Abstract][Full Text] [Related]
2. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
3. [Qualitatively reliable study proves: in chronic bronchitis or COPD--standardized Myrtol].
MMW Fortschr Med; 2004 May; 146(19):56-7. PubMed ID: 15357482
[No Abstract] [Full Text] [Related]
4. Effect of probiotics, prebiotics and synbiotics for chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Pei C; Wu Y; Wang X; Wang F; Liu L
Medicine (Baltimore); 2020 Nov; 99(45):e23045. PubMed ID: 33157958
[TBL] [Abstract][Full Text] [Related]
5. Effect of acupuncture on chronic bronchitis: A protocol for systematic review and meta-analysis.
Mao D; Deng Y; Zhang L; Zhao Y; Li Y; Wang F
Medicine (Baltimore); 2020 Jun; 99(24):e20676. PubMed ID: 32541514
[TBL] [Abstract][Full Text] [Related]
6. Gelomyrtol for acute or chronic sinusitis: A protocol for systematic review and meta-analysis.
Wu Y; Wang X; Huang D; Pei C; Li S; Wang Z
Medicine (Baltimore); 2020 Jun; 99(23):e20611. PubMed ID: 32502036
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
[TBL] [Abstract][Full Text] [Related]
8. Telehealth for patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis protocol.
Gaveikaite V; Fischer C; Schonenberg H; Pauws S; Kitsiou S; Chouvarda I; Maglaveras N; Roca J
BMJ Open; 2018 Sep; 8(9):e021865. PubMed ID: 30232108
[TBL] [Abstract][Full Text] [Related]
9. The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review.
Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
Medicine (Baltimore); 2019 Nov; 98(46):e17996. PubMed ID: 31725666
[TBL] [Abstract][Full Text] [Related]
10. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Sathananthan K; Fortescue R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
Papi A; Alfano F; Bigoni T; Mancini L; Mawass A; Baraldi F; Aljama C; Contoli M; Miravitlles M
Arch Bronconeumol; 2024 May; 60(5):269-278. PubMed ID: 38555190
[TBL] [Abstract][Full Text] [Related]
12. Levels of immunoglobulin isotypes in serum and respiratory samples of patients with chronic obstructive pulmonary disease: protocol for a systematic review and meta-analysis.
Unninayar D; Shea B; Cameron DW; Cowan J
BMJ Open; 2023 Feb; 13(2):e064307. PubMed ID: 36759034
[TBL] [Abstract][Full Text] [Related]
13. The effect of myrtol standardized on human nasal ciliary beat frequency and mucociliary transport time.
Han D; Wang N; Zhang L
Am J Rhinol Allergy; 2009; 23(6):610-4. PubMed ID: 19822035
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and safety of Chinese medicines for the treatment of uveitis: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Qin Y; Meng H; Chen Y; Wang Z; Jin M
Medicine (Baltimore); 2020 Jun; 99(26):e20766. PubMed ID: 32590753
[TBL] [Abstract][Full Text] [Related]
15. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
16. Validation of acute exacerbation of chronic obstructive pulmonary disease (COPD) recording in electronic health records: a systematic review protocol.
Stone P; Sood N; Feary J; Roberts CM; Quint JK
BMJ Open; 2020 Feb; 10(2):e032467. PubMed ID: 32111611
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of mindfulness-based interventions for patients with COPD: a systematic review and meta-analysis protocol.
Tian L; Zhang Y; Li L; Wu Y; Li Y
BMJ Open; 2019 May; 9(5):e026061. PubMed ID: 31142522
[TBL] [Abstract][Full Text] [Related]
18. Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease.
Cao L; Chen Y; Zhao Y; Zhang H; Wang S; Wang Z; Kang J
Arzneimittelforschung; 2011; 61(12):685-92. PubMed ID: 22282955
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease.
Rantzsch U; Vacca G; Dück R; Gillissen A
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):205-9. PubMed ID: 20156758
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Chinese medicines for vitreous hemorrhage: A protocol for systematic review and meta-analysis.
Han M; Liu Z; Nong L; Zi Y; Meng H; Deng Y; Wang ZJ; Jin M
Medicine (Baltimore); 2020 May; 99(19):e20086. PubMed ID: 32384479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
